Bringing optimised COVID-19 vaccine schedules to immunocompromised populations (BOOST-IC): study protocol for an adaptive randomised controlled clinical trial.

David W J GriffinMichael DymockGermaine WongC Orla MorrisseySharon R LewinAllen C ChengKirsten HowardJulie A MarshKanta SubbaraoMichelle HagenauerJanine RoneyAnthony CunninghamTom SnellingJames H McMahon

Published in: Trials (2024)

ClinicalTrials.gov NCT05556720. Registered on 23rd August 2022.

Keyphrases

clinical trial
coronavirus disease
study protocol
sars cov
phase ii
open label
double blind
randomized controlled trial
respiratory failure
respiratory syndrome coronavirus
phase iii
placebo controlled
acute respiratory distress syndrome